An eight-year clinic experience with clozapine use in a Parkinson's disease clinic setting.
<h4>Background</h4>To examine our eight year clinic-based experience in a Parkinson's disease expert clinical care center using clozapine as a treatment for refractory psychosis in Parkinson's disease (PD).<h4>Methods</h4>The study was a retrospective chart review w...
Guardado en:
Autores principales: | Nawaz Hack, Sarah M Fayad, Erin H Monari, Umer Akbar, Angela Hardwick, Ramon L Rodriguez, Irene A Malaty, Janet Romrell, Aparna A Wagle Shukla, Nikolaus McFarland, Herbert E Ward, Michael S Okun |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ffe5b2d2639649b7a94244aa1b73384c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The "brittle response" to Parkinson's disease medications: characterization and response to deep brain stimulation.
por: Daniel Martinez-Ramirez, et al.
Publicado: (2014) -
Clinical predictors of response to clozapine in Tunisian patients with treatment resistant schizophrenia
por: Amina Aissa, et al.
Publicado: (2022) -
Clozapine-induced seizures, electroencephalography abnormalities, and clinical responses in Japanese patients with schizophrenia
por: Kikuchi YS, et al.
Publicado: (2014) -
A survey of personnel and services offered in 32 outpatient US clozapine clinics
por: Robert O. Cotes, et al.
Publicado: (2021) -
Clozapine As Transformative Treatment In Bipolar Patients
por: Wilkowska A, et al.
Publicado: (2019)